The abstract is read at the publisher; the summary is JClub's.
A genomics-metabolomics pipeline for Myxococcota myxobacteria yielded 12 (seco-)steroids from 2 strains, including 4 previously undescribed structures with diverse oxidative and ring modifications.
- Why it matters: Steroid diversity and biosynthetic evolution in myxobacteria are poorly mapped, limiting insight into their catalytic potential and pharmacological relevance.
- What they did: The authors surveyed myxobacterial genomes for sterol biosynthetic genes and found dispersed chromosomal organization, then used sequence network mining of oxidosqualene cyclases plus chromatographic pre-fractionation with NMR-based metabolic profiling to guide isolation.
- The result: Bioactivity testing showed an alkylglycoside co-metabolite synergistically potentiates antimicrobial activity of select secosteroids, enabling discovery of cryptic sterol metabolites and their hidden functions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.